These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9036965)
21. Molecular dynamics simulation of a high-affinity antibody-protein complex: the binding site is a mosaic of locally flexible and preorganized rigid regions. Sinha N; Smith-Gill SJ Cell Biochem Biophys; 2005; 43(2):253-73. PubMed ID: 16049350 [TBL] [Abstract][Full Text] [Related]
22. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. Jespers L; Schon O; James LC; Veprintsev D; Winter G J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359 [TBL] [Abstract][Full Text] [Related]
23. Crystallization and preliminary X-ray diffraction study of an idiotope-anti-idiotope Fv-Fv complex. Goldbaum FA; Fields BA; Cauerhff A; Ysern X; Houdusse A; Eisele JL; Poljak RJ; Mariuzza RA J Mol Biol; 1994 Sep; 241(5):739-43. PubMed ID: 8071997 [TBL] [Abstract][Full Text] [Related]
24. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains. Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019 [TBL] [Abstract][Full Text] [Related]
25. Structural effects of framework mutations on a humanized anti-lysozyme antibody. Holmes MA; Buss TN; Foote J J Immunol; 2001 Jul; 167(1):296-301. PubMed ID: 11418663 [TBL] [Abstract][Full Text] [Related]
26. Dissection of the IgNAR V domain: molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms. Fennell BJ; Darmanin-Sheehan A; Hufton SE; Calabro V; Wu L; Müller MR; Cao W; Gill D; Cunningham O; Finlay WJ J Mol Biol; 2010 Jul; 400(2):155-70. PubMed ID: 20450918 [TBL] [Abstract][Full Text] [Related]
27. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions. Sompuram SR; Den W; Sharon J J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981 [TBL] [Abstract][Full Text] [Related]
28. A human antibody fragment with high affinity for biodegradable polymer film. Watanabe H; Tsumoto K; Taguchi S; Yamashita K; Doi Y; Nishimiya Y; Kondo H; Umetsu M; Kumagai I Bioconjug Chem; 2007; 18(3):645-51. PubMed ID: 17385839 [TBL] [Abstract][Full Text] [Related]
29. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain. Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181 [TBL] [Abstract][Full Text] [Related]
30. Crystal structure of a phage library-derived single-chain Fv fragment complexed with turkey egg-white lysozyme at 2.0 A resolution. Aÿ J; Keitel T; Küttner G; Wessner H; Scholz C; Hahn M; Höhne W J Mol Biol; 2000 Aug; 301(2):239-46. PubMed ID: 10926506 [TBL] [Abstract][Full Text] [Related]
31. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. Mylvaganam SE; Paterson Y; Getzoff ED J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550 [TBL] [Abstract][Full Text] [Related]
32. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs. Potter KN; Li Y; Capra JD J Immunol; 1996 Oct; 157(7):2982-8. PubMed ID: 8816406 [TBL] [Abstract][Full Text] [Related]
33. X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65. Eigenbrot C; Gonzalez T; Mayeda J; Carter P; Werther W; Hotaling T; Fox J; Kessler J Proteins; 1994 Jan; 18(1):49-62. PubMed ID: 7908437 [TBL] [Abstract][Full Text] [Related]
34. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535 [TBL] [Abstract][Full Text] [Related]
35. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity. Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458 [TBL] [Abstract][Full Text] [Related]
36. The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains. Honegger A; Plückthun A J Mol Biol; 2001 Jun; 309(3):687-99. PubMed ID: 11397089 [TBL] [Abstract][Full Text] [Related]
37. A mutational analysis of the binding of two different proteins to the same antibody. Dall'Acqua W; Goldman ER; Eisenstein E; Mariuzza RA Biochemistry; 1996 Jul; 35(30):9667-76. PubMed ID: 8703938 [TBL] [Abstract][Full Text] [Related]
38. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains. Narayanan A; Sellers BD; Jacobson MP J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053 [TBL] [Abstract][Full Text] [Related]
39. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Jones PT; Dear PH; Foote J; Neuberger MS; Winter G Nature; 1986 May 29-Jun 4; 321(6069):522-5. PubMed ID: 3713831 [TBL] [Abstract][Full Text] [Related]
40. Structure of a non-camelized human M12-V(H) domain at 1.5A resolution. Gaur RK J Struct Biol; 2005 Oct; 152(1):84-9. PubMed ID: 16183303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]